Clinical Trial Detail

NCT ID NCT02134886
Title Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Erlotinib

Age Groups: adult

Additional content available in CKB BOOST